American Rhinologic Society 70th Annual Meeting 2024
Include: 64 videos + 1 pdf, size: 2.49 GB
Target Audience: otolaryngologists, rhinologists and sinus surgeons
Information:
The 70th Annual Meeting of the American Rhinologic Society (ARS) will take place on September 27–28, 2024, at the Fontainebleau Miami Beach in Miami, Florida.
Here’s what you can expect:
- Scientific Program: Presentations on cutting-edge research, including topics like machine learning in endoscopy and sinonasal pathology
- Networking: A chance to connect with leaders in rhinology and sinus surgery
- Poster Awards: Recognizing outstanding research contributions
The annual meeting occurs each fall at the time of the annual meeting of the Academy of Otolaryngology – Head & Neck Society.
The ARS is the only professional organization that deals specifically with issues of sinus surgery, both conventional and endoscopic. The ARS promotes excellence in clinical care, investigation and education in the fields of Rhinology and Sinusology. The ARS is dedicated to providing communication and fellowship to its members through ongoing continuing medical education, economic and social programs.
The 70th Annual Meeting of the American Rhinologic Society (ARS) is tailored for professionals involved in the field of rhinology and sinus surgery. The primary target audience includes:
- Otolaryngologists (ENT specialists)
- Rhinologists and sinus surgeons
- Physician assistants and advanced practice providers in ENT
- Medical researchers and academics in rhinologic science
- Residents and fellows specializing in otolaryngology
Topics:
- ARS.70thAnnMtg.PAAG.pdf
Day 1 General Session 20th Annual David Kennedy Lectureship Drug Development- From Discovery to the Clinic.mp4
Day 1 General Session AI prediction of IP conversion to SCC using a multi-institutional CT dataset.mp4
Day 1 General Session Awards Ceremony IFAR Top Reviewers Recognition 1.mp4
Day 1 General Session Awards Ceremony IFAR Top Reviewers Recognition 2.mp4
Day 1 General Session Deletion of Nrf2 enhances susceptibility to type 2 inflammation after short term PM2.5 exposure.mp4
Day 1 General Session Long term outcomes of PRP injections for postviral olfactory loss.mp4
Day 1 General Session Maurice Cottle – Our Founder Tribute.mp4
Day 1 General Session Murine model of nose-to-brain delivery of antibodies using minimally invasive nasal depot (MIND).mp4
Day 1 General Session Panel- CRS- Where are we Headed in Research and Patient Care.mp4
Day 1 General Session Pathologic dural invasion is associated with regional recurrence in olfactory neuroblastoma.mp4
Day 1 General Session President’s Address.mp4
Day 1 General Session Q&A 1.mp4
Day 1 General Session Q&A 2.mp4
Day 1 General Session Sinus microbial community changes in chronic rhinosinusitis over one year.mp4
Day 1 General Session Stem cell therapy to treat Cystic Fibrosis rhinosinusitis.mp4
Day 1 General Session Steroid-eluting sinus stent versus steroid rinse for maintaining frontal sinus patency.mp4
Day 1 General Session The effects of allergen immunotherapy (AIT) postsurgery in patients with central compartment atopic disease (CCAD).mp4
Day 1 General Session Therapeutic efficacy of the Ciprofloxacin Azithromycin sinus stent for p.aeruginosa sinusitis.mp4
Day 2 General Session 3rd Annual Hwang Family Lectureship.mp4
Day 2 General Session ARS Business Meeting and Presidential Citations.mp4
Day 2 General Session Autonomic dysfunction and olfactory loss in long COVID.mp4
Day 2 General Session Deep learning approach for automated frontal sinus opacification assessment on CT scan.mp4
Day 2 General Session Immunophenotyping invasive fungal sinusitis survival.mp4
Day 2 General Session Inflammatory endotypes in CRSwNP- Implications for postop outcomes.mp4
Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 1.mp4
Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 2.mp4
Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 3.mp4
Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 4.mp4
Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 5.mp4
Day 2 General Session Intro.mp4
Day 2 General Session Olfactory cleft opacification and outcomes improve with expanded intranasal steroid treatment.mp4
Day 2 General Session Olfactory fossa opacification on CT scan is correlated to nasal IL-5 in chronic rhinosinusitis.mp4
Day 2 General Session Panel- ARS AAOA – Empty Nose Syndrome- Just a Bunch of Hot Air.mp4
Day 2 General Session PAR2 activated IL13 Ra1 in eCRS.mp4
Day 2 General Session Prevalence of Cystic Fibrosis carrier status in chronic rhinosinusitis without nasal polyps.mp4
Day 2 General Session Q&A 1.mp4
Day 2 General Session Q&A 2.mp4
Day 2 General Session Token of appreciation.mp4
Day 2 Skull Base – Breakout 1 Assessing complications of functional endoscopic sinus surgery in a large national database.mp4
Day 2 Skull Base – Breakout 1 Assessing the impact of GLP-1R agonists in postsinus surgery management.mp4
Day 2 Skull Base – Breakout 1 Autologous vs synthetic inlay grafts have comparable skull base reconstructive outcomes.mp4
Day 2 Skull Base – Breakout 1 Debate- Approaches to the Lateral Frontal Sinus.mp4
Day 2 Skull Base – Breakout 1 Extended approaches to the maxillary sinus and empty nose syndrome.mp4
Day 2 Skull Base – Breakout 1 Factors influencing CSF leak timing after ESBS.mp4
Day 2 Skull Base – Breakout 1 Long-term implications of short-term outcomes after ESS in CRS patients.mp4
Day 2 Skull Base – Breakout 1 Maxillary antrostomy alone versus complete sinus surgery for odontogenic sinusitis.mp4
Day 2 Skull Base – Breakout 1 Mutational burden assessment in sinonasal squamous cell carcinoma survival.mp4
Day 2 Skull Base – Breakout 1 Orbital decompression in the biologic era- Is there still a need for surgery.mp4
Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 1.mp4
Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 2.mp4
Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 3.mp4
Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 4.mp4
Day 2 Skull Base – Breakout 1 Panel- “Carve it Out or Melt it Away – Induction Chemotherapy versus Upfront Surgery for Sinonasal Malignancies”.mp4
Day 2 Skull Base – Breakout 1 Q&A 1.mp4
Day 2 Skull Base – Breakout 1 Q&A 2.mp4
Day 2 Skull Base – Breakout 1 Q&A 3.mp4
Day 2 Skull Base – Breakout 1 Q&A 4.mp4
Day 2 Skull Base – Breakout 1 Retrobulbar amphotericin B injections versus orbital exenteration in AIFRS outcomes.mp4
Day 2 Skull Base – Breakout 1 Social vulnerability and quality of life before and after endoscopic skull base surgery.mp4
Day 2 Skull Base – Breakout 1 The effect of anticoagulant therapy on endoscopic sinus surgery postoperative outcomes.mp4
Day 2 Skull Base – Breakout 1 Understanding endoscopy and imaging frequency for detection of sinonasal SCC recurrence.mp4
Day 2 Skull Base – Breakout 1 Unilateral versus bilateral resection of olfactory neuroblastoma.mp4
Day 2 Skull Base – Breakout 1 Upfront Draf III – Cost-effective in the long run.mp4
Day 2 Skull Base – Breakout 1 Validation of the sinonasal outcome test-22 in sinonasal malignancy.mp4
